Search Results - "Kentenich, C"

Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast Cancer by Braun, Stephan, Pantel, Klaus, Müller, Peter, Janni, Wolfgang, Hepp, Florian, Kentenich, Christina R.M, Gastroph, Stephan, Wischnik, Artur, Dimpfl, Thomas, Kindermann, Günter, Riethmüller, Gert, Schlimok, Günter

“…The search for occult metastatic cells in patients with small, curatively resected tumors is of considerable importance, because early dissemination of tumor…”
Get full text

Comparative Analysis of Micrometastasis to the Bone Marrow and Lymph Nodes of Node-Negative Breast Cancer Patients Receiving No Adjuvant Therapy by BRAUN, Stephan, CEVATLI, B. Semeni, ASSEMI, Cyamak, JANNI, Wolfgang, KENTENICH, Christina R. M, SCHINDLBECK, Christian, RJOSK, Dorothea, HEPP, Florian

“…In node-negative patients, of whom up to 30% will recur within 5 years after diagnosis, markers are still needed that identify patients at high enough risk to…”
Get full text

Monoclonal Antibody Therapy with Edrecolomab in Breast Cancer Patients: Monitoring of Elimination of Disseminated Cytokeratin-positive Tumor Cells in Bone Marrow by BRAUN, S, HEPP, F, KENTENICH, C. R. M, JANNI, W, PANTEL, K, RIETHMÜLLER, G, WILLGEROTH, F, SOMMER, H. L

“…Despite current advances in antibody-based immunotherapy of breast and colorectal cancer, we have recently shown that the actual target cells ( e.g. , tumor…”
Get full text

Occult Tumor Cells in Bone Marrow of Patients With Locoregionally Restricted Ovarian Cancer Predict Early Distant Metastatic Relapse by BRAUN, Stephan, SCHINDLBECK, Christian, HEPP, Florian, JANNI, Wolfgang, KENTENICH, Christina, RIETHMÜLLER, Gert, PANTEL, Klaus

“…Based on conventional tumor staging, primary ovarian cancer is viewed as an intraperitoneal disease that rarely spreads to extraperitoneal organs. However,…”
Get full text

Weekly docetaxel (Taxotere®) in patients with metastatic breast cancer by Stemmler, H. J., Gutschow, K., Sommer, H., Malekmohammadi, M., Kentenich, Ch, Forstpointner, R., Geuenich, S., Bischoff, J., Hiddemann, W., Heinemann, V.

“…Summary Background: Docetaxel (Taxotere®) has demonstrated high antitumour activity in first- and second-line treatment of metastatic breast cancer. This study…”
Get full text

High efficacy and low toxicity of weekly docetaxel given as first-line treatment for metastatic breast cancer by Stemmler, J, Mair, W, Stauch, M, Papke, J, Deutsch, G, Abenhardt, W, Dorn, B, Kentenich, C, Malekmohammadi, M, Jackisch, C, Leinung, S, Brudler, O, Vehling-Kaiser, U, Stamp, J, Heinemann, V

“…Docetaxel is one of the most effective antitumor agents currently available for the treatment of metastatic breast cancer (MBC). This phase II multicenter…”
Get more information

Lack of Effect of Adjuvant Chemotherapy on the Elimination of Single Dormant Tumor Cells in Bone Marrow of High-Risk Breast Cancer Patients by BRAUN, S, KENTENICH, C, JANNI, W, HEPP, F, DE WAAL, J, WILLGEROTH, F, SOMMER, H, PANTEL, K

“…There is an urgent need for markers that can predict the efficacy of adjuvant chemotherapy in patients with solid tumors. This study was designed to evaluate…”
Get full text

Rare Expression of Epithelial Cell Adhesion Molecule on Residual Micrometastatic Breast Cancer Cells after Adjuvant Chemotherapy by THURM, Holger, EBEL, Sebastian, PANTEL, Klaus, KENTENICH, Christina, HEMSEN, Alice, RIETHDORF, Sabine, COITH, Cornelia, WALLWIENER, Diethelm, BRAUN, Stephan, OBERHOFF, Carsten, JÄNICKE, Fritz

“…Purpose: Over the past 5 years, several clinical studies on a total of ∼2500 patients have shown that the immunocytochemical detection of occult metastatic…”
Get full text

The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence by Janni, Wolfgang, Hepp, Florian, Rjosk, Dorothea, Kentenich, Christina, Strobl, Barbara, Schindlbeck, Christian, Hantschmann, Peer, Sommer, Harald, Pantel, Klaus, Braun, Stephan

“…BACKGROUND The current study examines the fate of occult metastatic cells detected in bone marrow (BM) at primary diagnosis and evaluates whether persistently…”
Get full text

Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma by Janni, Wolfgang, Gastroph, Stephan, Hepp, Florian, Kentenich, Christina, Rjosk, Dorothea, Schindlbeck, Christian, Dimpfl, Thomas, Sommer, Harald, Braun, Stephan

“…BACKGROUND Using cytokeratin (CK) as a histogenetic marker of epithelial tumor cells in the bone marrow of patients with primary breast carcinoma, a subgroup…”
Get full text

Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus by Janni, Wolfgang, Hepp, Florian, Strobl, Barbara, Rack, Brigitte, Rjosk, Dorothea, Kentenich, Christina, Schindlbeck, Christian, Hantschmann, Peer, Pantel, Klaus, Sommer, Harald, Braun, Stephan

“…BACKGROUND The presence of isolated tumor cells (ITC) in the bone marrow at the time of primary diagnosis indicates an increased risk for subsequent…”
Get full text

Influence of systemic therapy on the persistence of occult metastatic cells in bone marrow of breast cancer patients by Janni, W., Strobl, B., Rjosk, D., Kentenich, C., Hepp, F., Schindlbeck, C., Sommer, H., Braun, S.

Get full text

Preoperative hemoglobin levels do not influence the dissemination of isolated tumor cells in the bone marrow of breast cancer patients by Kentenich, C., Janni, W., Zerzer, M., Rjosk, D., Hepp, F., Schindlbeck, C.

Get full text

Persistence of occult metastatic cells in bone marrow of breast cancer patients despite systemic adjuvant treatment by Janni, W., Rack, B., Rjosk, D., Klanner, E., Kentenich, C., Schindlbeck, C., Braun, S., Sommer, H.

Get full text

Breast cancer and distant metastatic disease by Hoey, John

“…Many women with breast cancer that appears localized to the breast or to the breast and regional lymph nodes are believed to have undetectable distant…”
Get full text

423 Isolated tumor cells in the bone marrow (ITC-BM) of breast cancer patients before and after anthracyclin based therapy — Influenced by the HER2neu- and topoisomerase IIa-expression/amplification of the primary tumor? by Schindlbeck, C., Kornmeier, A., Janni, W., Shabani, N., Kentenich, C., Braun, S., Sommer, H., Friese, K.

Get full text

Effect of zoledronate on persisting disseminated tumor cells (DTC) in the bone marrow (BM) of breast cancer patients by Rack, B, Janni, W, Thieleke, W, Schindlbeck, C, Strobl, B, Kentenich, C, Blankenstein, T, Rjosk, D, Sommer, H, Friese, K

Get full text

The influence of the hemoglobin concentration on the hematogenous tumor cell dissemination at the time of the initial diagnosis of breast cancer by Janni, W, Strobl, B, Rack, B, Rjosk, D, Schindlbeck, C, Hantschmann, P, Kentenich, C, Sigg, W, Zerzer, M, Sommer, H

“…In the last few years special attention has been paid to the serum concentration of haemoglobin in patients with cancer. It was the aim of this study to…”
Get more information

Incidence and prognostic significance of disseminated tumor cells in patients with cervical cancer by Rack, B, Janni, W, Kentenich, C, Strobl, B, Klanner, E, Schindlbeck, C, Hepp, F, Sommer, H, Braun, S

“…The clinical course of cervical carcinoma is widely determined by locoregional recurrence. There is increasing data, however, that haematogenic micrometastases…”
Get more information